JACOBS LEVY EQUITY MANAGEMENT, INC

Position in CORT — Corcept Therapeutics Inc

CIK 884414 FLORHAM PARK, NJ

Position in CORT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$60,476,507

+$60,158,362 QoQ

Shares Held

695,532

+18069.6% QoQ

Ownership

0.643%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#23

of 415 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 74% Shared 0% None 26%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. CORT ranks #4 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc This page	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$60,476,507	695,532	+18069.6%	Shares	Sole	2026-08-14
2025-09-30	$318,145	3,828	-99.2%	Shares	Sole	2025-11-17
2025-06-30	$33,430,103	455,451	-66.3%	Shares	Sole	2025-08-14
2025-03-31	$154,160,678	1,349,682	-2.0%	Shares	Sole	2025-05-15
2024-12-31	$69,381,033	1,376,881	+12.5%	Shares	Sole	2025-02-14
2024-09-30	$56,636,584	1,223,781	+40.5%	Shares	Sole	2024-11-14
2024-06-30	$28,293,396	870,834	+19.1%	Shares	Sole	2024-08-14
2024-03-31	$18,425,678	731,468	+3.9%	Shares	Sole	2024-05-15
2020-09-30	$12,257,057	704,024	-19.0%	Shares	Sole	2020-11-16
2020-06-30	$14,623,308	869,400	+74.5%	Shares	Sole	2020-08-17
2020-03-31	$5,922,765	498,130	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.